Researcher.Life Logo

Expert Opinion on Drug Discovery : Impact Factor & More

eISSN: 1746-045XpISSN: 1746-0441

Aims and Scope of Expert Opinion on Drug Discovery

Expert Opinion on Drug Discovery is a monthly peer-reviewed medical journal publishing review articles on novel technologies involved in drug discovery. The editor-in-chief is David Janero from Northeastern University. Less

Key Metrics

CiteScore
8.5
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Drug Discovery
SNIP
1.17
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Opinion on Drug Discovery

Expert Opinion on Drug Discovery Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Opinion on Drug Discovery ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Opinion on Drug Discovery

In vitro prediction of the immunogenicity of therapeutic proteins: state of the art and current challenges and perspectives
  • 3 Jun 2026
  • Expert Opinion on Drug Discovery
The root cause: why do so many drugs fail to translate from bench to bedside?
  • 3 Jun 2026
  • Expert Opinion on Drug Discovery
The design of multi-target ligands and their role in schizophrenia therapy: an update
  • 9 May 2026
  • Expert Opinion on Drug Discovery
The application of fluorinated α-amino acids to drug discovery techniques
  • 8 May 2026
  • Expert Opinion on Drug Discovery
Multi-target approaches to prion disease drug discovery: a status update
  • 7 May 2026
  • Expert Opinion on Drug Discovery
Combining cutting edge computational and experimental methods for targeting kras mutations in non-small cell lung cancer
  • 4 May 2026
  • Expert Opinion on Drug Discovery
In vitro prediction of the immunogenicity of therapeutic proteins: state of the art and current challenges and perspectives
  • 3 Jun 2026
  • Expert Opinion on Drug Discovery
The root cause: why do so many drugs fail to translate from bench to bedside?
  • 3 Jun 2026
  • Expert Opinion on Drug Discovery
The design of multi-target ligands and their role in schizophrenia therapy: an update
  • 9 May 2026
  • Expert Opinion on Drug Discovery
The application of fluorinated α-amino acids to drug discovery techniques
  • 8 May 2026
  • Expert Opinion on Drug Discovery
Multi-target approaches to prion disease drug discovery: a status update
  • 7 May 2026
  • Expert Opinion on Drug Discovery
Combining cutting edge computational and experimental methods for targeting kras mutations in non-small cell lung cancer
  • 4 May 2026
  • Expert Opinion on Drug Discovery

FAQs on Expert Opinion on Drug Discovery